Drugs / Na134I
last change Dec 2014 re-read 2 minutes ago

Na134I

Developed for
breast cancer
Investigated by
Stanford University

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT01360177 Jul 2010 → Dec 2013 breast cancer Stanford University Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Na134I ClinicalTrials.gov intervention name — accepted as the source's own label NCT01360177